RESOLVING THE LEDGER

Single Source · MarketWatch

This is one outlet's own report from MarketWatch — the article as it was filed. Other outlets are covering the same event; open the full story to compare every source side by side.

See the full story · 1 sources

AIPROPX ReportMarketWatch · 1h ago

Lilly’s revenue soars 48%, driven by demand for its GLP-1s

Lilly’s sales were driven by higher-than-expected demand for Mounjaro and Zepbound, its GLP-1 drugs for Type 2 diabetes and weight loss.

Following

Method

Read it at the originRead the full report at MarketWatch

Share

◆ AIPROPX index record

Region: US
In this story: 1 of 1 reports · 1 outlets
Detected names: Lilly’sGLPMounjaroZepboundType

AIPROPX is an independent multi-source news index — we track, compare, and connect coverage from across the web into one place you won't find anywhere else.

Discover AIPROPX

LiveLive WireEvery report as it lands PopularTrendingMost-covered events now BrowseTop StoriesThe corroborated record FindSearchAny story, topic, or outlet